Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

<p>Abstract</p> <p>Background</p> <p>Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS...

Full description

Bibliographic Details
Main Authors: Aktas Esin, Sabanci Akin, Ermis Ezgi, Yazihan Nuray, Bilir Ayhan, Erguven Mine, Aras Yavuz, Alpman Vehbi
Format: Article
Language:English
Published: BMC 2011-06-01
Series:Cancer Cell International
Online Access:http://www.cancerci.com/content/11/1/18
id doaj-c0ee4007a05a48bf8924f9aabc9c077b
record_format Article
spelling doaj-c0ee4007a05a48bf8924f9aabc9c077b2020-11-24T20:55:01ZengBMCCancer Cell International1475-28672011-06-011111810.1186/1475-2867-11-18Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkineAktas EsinSabanci AkinErmis EzgiYazihan NurayBilir AyhanErguven MineAras YavuzAlpman Vehbi<p>Abstract</p> <p>Background</p> <p>Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM <it>in vitro </it>and the role of midkine (MK) in this new combination treatment.</p> <p>Methods</p> <p>Monolayer and spheroid cultures of T98G human GBM cell line were used to evaluate the effects of IM (10 μM), Nos (10 μM) and their combination on cell proliferation and apoptotic indexes, cell cycle, the levels of antiapoptotic MK, MRP-1, p170, PFGFR-α, EGFR, bcl-2 proteins, apoptotic caspase-3 levels, morphology (SEM) and ultrastructure (TEM) for 72 hrs. Results were statistically analyzed using the Student's t-test.</p> <p>Results</p> <p>The combination group induced highest decrease in cell proliferation and apoptotic indexes, caspase-3 levels, MRP-1 and PDGFR-α levels. The decrease in p170 levels were lower than IM but higher that NOS. The highest increases were in EGFR, MK, bcl-2 and cAMP levels in the combination group. The G0+G1 cell cycle arrest at the end of 72<sup>nd </sup>hr was the lowest in the combination group. Apoptotic appearence was observed rarely both in the morphologic and ultrastructural evaluation of the combination group. In addition, autophagic vacuoles which were frequently observed in the IM group were observed rarely.</p> <p>Conclusions</p> <p>The combination of Nos with IM showed antagonist effect in T98G human GBM cells in vitro. This antagonist effect was correlated highly with MK levels. The effects of NOS on MRP-1, MK and receptor tyrosine kinase levels were firstly demonstrated in our report. In addition, we proposed that MK is one of the modulator in the switch of autophagy to cell death or survival/resistance.</p> http://www.cancerci.com/content/11/1/18
collection DOAJ
language English
format Article
sources DOAJ
author Aktas Esin
Sabanci Akin
Ermis Ezgi
Yazihan Nuray
Bilir Ayhan
Erguven Mine
Aras Yavuz
Alpman Vehbi
spellingShingle Aktas Esin
Sabanci Akin
Ermis Ezgi
Yazihan Nuray
Bilir Ayhan
Erguven Mine
Aras Yavuz
Alpman Vehbi
Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
Cancer Cell International
author_facet Aktas Esin
Sabanci Akin
Ermis Ezgi
Yazihan Nuray
Bilir Ayhan
Erguven Mine
Aras Yavuz
Alpman Vehbi
author_sort Aktas Esin
title Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
title_short Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
title_full Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
title_fullStr Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
title_full_unstemmed Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
title_sort decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine
publisher BMC
series Cancer Cell International
issn 1475-2867
publishDate 2011-06-01
description <p>Abstract</p> <p>Background</p> <p>Glioblastoma (GBM) develops resistance to the advances in chemotherapy leading to poor prognosis and life quality. Consequently, new treatment modalities are needed. Our aims were to investigate the effects of combined noscapine (NOS) and imatinib mesylate (IM) on human GBM <it>in vitro </it>and the role of midkine (MK) in this new combination treatment.</p> <p>Methods</p> <p>Monolayer and spheroid cultures of T98G human GBM cell line were used to evaluate the effects of IM (10 μM), Nos (10 μM) and their combination on cell proliferation and apoptotic indexes, cell cycle, the levels of antiapoptotic MK, MRP-1, p170, PFGFR-α, EGFR, bcl-2 proteins, apoptotic caspase-3 levels, morphology (SEM) and ultrastructure (TEM) for 72 hrs. Results were statistically analyzed using the Student's t-test.</p> <p>Results</p> <p>The combination group induced highest decrease in cell proliferation and apoptotic indexes, caspase-3 levels, MRP-1 and PDGFR-α levels. The decrease in p170 levels were lower than IM but higher that NOS. The highest increases were in EGFR, MK, bcl-2 and cAMP levels in the combination group. The G0+G1 cell cycle arrest at the end of 72<sup>nd </sup>hr was the lowest in the combination group. Apoptotic appearence was observed rarely both in the morphologic and ultrastructural evaluation of the combination group. In addition, autophagic vacuoles which were frequently observed in the IM group were observed rarely.</p> <p>Conclusions</p> <p>The combination of Nos with IM showed antagonist effect in T98G human GBM cells in vitro. This antagonist effect was correlated highly with MK levels. The effects of NOS on MRP-1, MK and receptor tyrosine kinase levels were firstly demonstrated in our report. In addition, we proposed that MK is one of the modulator in the switch of autophagy to cell death or survival/resistance.</p>
url http://www.cancerci.com/content/11/1/18
work_keys_str_mv AT aktasesin decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT sabanciakin decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT ermisezgi decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT yazihannuray decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT bilirayhan decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT erguvenmine decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT arasyavuz decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
AT alpmanvehbi decreasedtherapeuticeffectsofnoscapinecombinedwithimatinibmesylateonhumanglioblastomainvitroandtheeffectofmidkine
_version_ 1716792929234714624